ID: ALA2381021

Max Phase: Preclinical

Molecular Formula: C17H19ClN2O4

Molecular Weight: 350.80

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  O=C1CC(=O)N(C[C@H]2CCCO2)C(=O)N1CCc1cccc(Cl)c1

Standard InChI:  InChI=1S/C17H19ClN2O4/c18-13-4-1-3-12(9-13)6-7-19-15(21)10-16(22)20(17(19)23)11-14-5-2-8-24-14/h1,3-4,9,14H,2,5-8,10-11H2/t14-/m1/s1

Standard InChI Key:  KGTWIWDFJMQFRA-CQSZACIVSA-N

Associated Targets(non-human)

CACNA1C Voltage-gated L-type calcium channel alpha-1C subunit (335 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Cacna1d Voltage-gated L-type calcium channel alpha-1D subunit (336 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 350.80Molecular Weight (Monoisotopic): 350.1033AlogP: 2.24#Rotatable Bonds: 5
Polar Surface Area: 66.92Molecular Species: ACIDHBA: 4HBD: 0
#RO5 Violations: 0HBA (Lipinski): 6HBD (Lipinski): 0#RO5 Violations (Lipinski): 0
CX Acidic pKa: 5.00CX Basic pKa: CX LogP: 2.21CX LogD: -0.12
Aromatic Rings: 1Heavy Atoms: 24QED Weighted: 0.76Np Likeness Score: -1.06

References

1. Kang S, Cooper G, Dunne SF, Luan CH, Surmeier DJ, Silverman RB..  (2013)  Structure-activity relationship of N,N'-disubstituted pyrimidinetriones as Ca(V)1.3 calcium channel-selective antagonists for Parkinson's disease.,  56  (11): [PMID:23651412] [10.1021/jm4005048]

Source